Belite Bio (BLTE) Other Gross PP&E Adjustments (2021 - 2025)
Belite Bio's (BLTE) quarterly Other Gross PP&E Adjustments came in at $103000.0 in Q4 2025, up 319.15% year-on-year from $24573.6 in Q4 2024, and up 120.24% quarter-over-quarter from -$509000.0 in Q3 2025.
Belite Bio (BLTE) Other Gross PP&E Adjustments (2021 - 2025) Analysis & Trends
Belite Bio's Other Gross PP&E Adjustments history runs 5 years deep, the most recent figure standing at $103000.0 for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 319.15% year-over-year to $103000.0 in Q4 2025; TTM through Dec 2025 was $103000.0, a 319.15% increase from a year earlier, with the FY2025 full-year figure at $103000.0, up 319.15% from the prior year.
- Other Gross PP&E Adjustments climbed to $103000.0 in Q4 2025 per BLTE's latest filing, from -$509000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $141000.0 in Q4 2021 and bottomed at -$624000.0 in Q4 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$278000.0 (2024), against an average of -$259166.7.
- Across the five-year window, Other Gross PP&E Adjustments plunged 539.01% in 2022 and jumped 319.15% in 2025, its largest moves.
- Year by year, Other Gross PP&E Adjustments stood at $141000.0 in 2021, then plunged by 539.01% to -$619000.0 in 2022, then dropped by 0.81% to -$624000.0 in 2023, then surged by 92.47% to -$47000.0 in 2024, then soared by 319.15% to $103000.0 in 2025.
- Per Business Quant, the three latest BLTE Other Gross PP&E Adjustments figures stand at $103000.0 (Q4 2025), -$509000.0 (Q3 2025), and -$47000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -3.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -1.69 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -67.74 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | -189.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | -509,000.00 |
| Sep 30, 2025 | -509,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2023 | -624,000.00 |
| Dec 31, 2023 | -624,000.00 |
| Dec 31, 2022 | -619,000.00 |
| Dec 31, 2022 | -619,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Dec 31, 2021 | 141,000.00 |